Ibuprofen: Assay Workflows for Cancer Research

2026-09-09

Build more interpretable Ibuprofen experiments by separating COX pathway activity, cytotoxicity, apoptosis, and cell-cycle effects. This workflow combines practical dosing controls with protein-binding considerations inspired by a mechanistic reference study.

TBST: From Assay Clarity to Translational Confidence

2026-09-08

TBST is more than a routine wash solution: its detergent-buffer chemistry can influence background, antibody accessibility, and the confidence of translational evidence. This article connects TBST workflow design with the orthogonal validation strategy used to investigate uPAR–uPA inhibition in breast cancer metastasis.

Integrating Transcriptomics and Function in Cardiomyocytes

2026-09-08

Tsai and colleagues show that human iPSC-derived cardiomyocytes can support chemical hazard prioritization when transcriptomic responses are interpreted alongside beat and cytotoxicity phenotypes. Across 464 chemicals, this integrated design connected concentration-response points of departure with exposure-informed risk characterization and improved mechanistic interpretation.

Methotrexate Workflows for DHFR and Immune Studies

2026-09-07

Build reproducible Methotrexate assays around DHFR inhibition, exposure history, and activation-state biology. This guide distinguishes apoptosis induction in activated T cells from broader proliferation arrest while translating folate-pathway insights into practical controls and troubleshooting steps.

PDK4 Inhibitors for Metabolic Disease: Study Analysis

2026-09-07

Cisplatin Workflows for Resistance and Apoptosis

2026-09-05

Build reproducible Cisplatin and CDDP experiments around DNA damage, apoptosis, oxidative stress, and acquired resistance. This workflow translates a gefitinib-sensitization study into practical cell-based and xenograft assay decisions.

Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301)

2026-09-04

Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, nucleic acids, peptides, antibodies, sugars, and other targets from complex samples. They are best suited to biotin-dependent purification, immunoprecipitation, interaction assays, and screening workflows, but not to samples lacking a validated biotin handle or applications requiring a different capture chemistry.

BMS-777607 in MET and Platelet Research

2026-09-04

BMS-777607 combines potent MET-family kinase inhibition with a practical workflow for studying c-Met signaling, invasion, and metastatic phenotypes. This guide distinguishes validated oncology benchmarks from exploratory applications in hiPSC-derived platelet research, helping researchers design cleaner assays and troubleshoot reproducibility problems.

Mifepristone (RU486) Research Workflows

2026-09-03

Build reproducible Mifepristone and RU486 experiments for progesterone receptor biology, oncology, sperm-function studies, and integrated phenotypic-transcriptomic profiling. This guide emphasizes concentration-response design, orthogonal endpoints, and practical troubleshooting rather than relying on viability data alone.

Alosetron in Intestinal Signaling Research

2026-09-03

Alosetron provides a selective 5-HT3 receptor antagonist strategy for separating serotonin-dependent gut signaling from CDC42-driven epithelial fate control. This article translates the CDC42–YAP–EGFR–mTOR study into a practical, limitation-aware framework for intestinal organoid and visceral pain signaling research.

Disulfiram in APC-Deficient Colorectal Cancer

2026-09-02

Disulfiram is more than a dopamine β-hydroxylase inhibitor: emerging evidence positions it as a genotype-selective probe in APC-deficient colorectal cancer. This article connects ALDH2 inhibition, ROS/ASK1/JNK signaling, proteasome biology, and practical assay design while distinguishing established findings from research hypotheses.

Fluconazole: Reading Resistance in Fungal Assays

2026-09-02

Fluconazole is a fungal cytochrome P450 enzyme 14α-demethylase inhibitor used to connect ergosterol disruption with measurable fungal phenotypes. This guide presents a resistance-aware framework for assay design, comparator selection, and interpretation across susceptibility testing and infection models.

EZ Cap™ Mouse IL-12 mRNA (m1Ψ) Workflow

2026-09-01

Build reproducible IL-12 expression experiments with a Cap 1, poly(A)-tailed, m1Ψ-modified mouse cytokine transcript. This workflow connects intracellular expression assays with emerging extrahepatic delivery platforms, including virus-mimicking particles designed for lung and spleen targeting.

BMS-777607: A c-Met Inhibitor for Assay Design

2026-09-01

BMS-777607 is a selective c-Met inhibitor with activity across MET-family kinases. This article connects its oncology pharmacology with hiPSC-derived platelet research while defining evidence boundaries, assay controls, and practical protocol decisions.

Ethacridine lactate monohydrate in assay workflows

2026-08-31

Ethacridine lactate monohydrate supports practical microbial-control screens around stem-cell differentiation and biochemical assays without being misclassified as a YAP–TEAD pathway probe. This workflow-focused guide covers preparation, compatibility testing, assay controls, and troubleshooting for more defensible surface ectoderm experiments.